Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX
- PMID: 15016870
- PMCID: PMC371045
- DOI: 10.1128/jvi.78.7.3470-3479.2004
Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX
Abstract
The efficiency and specificity of gene transfer with human adenovirus (hAd)-derived gene transfer vectors would be improved if the native viral tropism could be modified. Here, we demonstrate that the minor capsid protein IX (pIX), which is present in 240 copies in the Ad capsid, can be exploited as an anchor for heterologous polypeptides. Protein IX-deleted hAd5 vectors were propagated in hAd5 helper cells expressing pIX variants, with heterologous carboxyl-terminal extensions of up to 113 amino acids in length. The extensions evaluated consist of alpha-helical spacers up to 75 A in length and to which peptide ligands were fused. The pIX variants were efficiently incorporated into the capsids of Ad particles. On intact particles, the MYC-tagged-pIX molecules were readily accessible to anti-MYC antibodies, as demonstrated by electron microscopic analyses of immunogold-labeled virus particles. The labeling efficiency improved with increasing spacer length, suggesting that the spacers lift and expose the ligand at the capsid surface. Furthermore, we found that the addition of an integrin-binding RGD motif to the pIX markedly stimulated the transduction of coxsackievirus group B and hAd receptor-deficient endothelioma cells, demonstrating the utility of pIX modification in gene transfer. Our data demonstrate that the minor capsid protein IX can be used as an anchor for the addition of polypeptide ligands to Ad particles.
Figures






Similar articles
-
Bovine adenovirus type 3 containing heterologous protein in the C-terminus of minor capsid protein IX.Virology. 2004 Mar 15;320(2):291-300. doi: 10.1016/j.virol.2003.12.007. Virology. 2004. PMID: 15016551
-
Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid.Gene Ther. 2007 Apr;14(8):664-70. doi: 10.1038/sj.gt.3302908. Epub 2007 Feb 1. Gene Ther. 2007. PMID: 17268536 Free PMC article.
-
Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.J Virol. 2002 Jul;76(14):6893-9. doi: 10.1128/jvi.76.14.6893-6899.2002. J Virol. 2002. PMID: 12072490 Free PMC article.
-
Adenovirus protein IX: a new look at an old protein.Mol Ther. 2005 Jan;11(1):19-25. doi: 10.1016/j.ymthe.2004.09.018. Mol Ther. 2005. PMID: 15585402 Review.
-
Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.Virus Res. 2018 Sep 15;257:40-51. doi: 10.1016/j.virusres.2018.08.012. Epub 2018 Aug 17. Virus Res. 2018. PMID: 30125593 Review.
Cited by
-
Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Viruses. 2010 Oct;2(10):2290-2355. doi: 10.3390/v2102290. Epub 2010 Oct 13. Viruses. 2010. PMID: 21994621 Free PMC article.
-
Designer Oncolytic Adenovirus: Coming of Age.Cancers (Basel). 2018 Jun 14;10(6):201. doi: 10.3390/cancers10060201. Cancers (Basel). 2018. PMID: 29904022 Free PMC article. Review.
-
Transductional targeting of adenovirus vectors for gene therapy.Cancer Gene Ther. 2006 Sep;13(9):830-44. doi: 10.1038/sj.cgt.7700928. Epub 2006 Jan 27. Cancer Gene Ther. 2006. PMID: 16439993 Free PMC article. Review.
-
Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.J Virol. 2010 Feb;84(4):1967-76. doi: 10.1128/JVI.01840-09. Epub 2009 Dec 9. J Virol. 2010. PMID: 20007267 Free PMC article.
-
Adenoviral vector-based strategies for cancer therapy.Curr Drug ther. 2009 May 1;4(2):117-138. doi: 10.2174/157488509788185123. Curr Drug ther. 2009. PMID: 20160875 Free PMC article.
References
-
- Assa-Munt, N., X. Jia, P. Laakkonen, and E. Ruoslahti. 2001. Solution structures and integrin binding activities of an RGD peptide with two isomers. Biochemistry 40:2373-2378. - PubMed
-
- Barnett, B. G., C. J. Crews, and J. T. Douglas. 2002. Targeted adenoviral vectors. Biochim. Biophys. Acta 1575:1-14. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources